Viibryd (Vilazodone) Market, Global Outlook and Forecast 2022-2028

April 2022 | 72 pages | ID: V2473BAE3006EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Viibryd (Vilazodone) in global, including the following market information:

Global Viibryd (Vilazodone) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Viibryd (Vilazodone) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Viibryd (Vilazodone) companies in 2021 (%)

The global Viibryd (Vilazodone) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

10 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Viibryd (Vilazodone) include Allergan plc (AbbVie Inc.), Actavis Generics (Teva) and Clinical Data, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viibryd (Vilazodone) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Viibryd (Vilazodone) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Viibryd (Vilazodone) Market Segment Percentages, by Type, 2021 (%)

• 10 mg
• 20 mg
• 40 mg

Global Viibryd (Vilazodone) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Viibryd (Vilazodone) Market Segment Percentages, by Application, 2021 (%)

• Major Depression
• Anxiety
• Others

Global Viibryd (Vilazodone) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Viibryd (Vilazodone) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Viibryd (Vilazodone) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Viibryd (Vilazodone) revenues share in global market, 2021 (%)

Key companies Viibryd (Vilazodone) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Viibryd (Vilazodone) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan plc (AbbVie Inc.)
• Actavis Generics (Teva)
• Clinical Data, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Viibryd (Vilazodone) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Viibryd (Vilazodone) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VIIBRYD (VILAZODONE) OVERALL MARKET SIZE

2.1 Global Viibryd (Vilazodone) Market Size: 2021 VS 2028
2.2 Global Viibryd (Vilazodone) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Viibryd (Vilazodone) Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Viibryd (Vilazodone) Players in Global Market
3.2 Top Global Viibryd (Vilazodone) Companies Ranked by Revenue
3.3 Global Viibryd (Vilazodone) Revenue by Companies
3.4 Global Viibryd (Vilazodone) Sales by Companies
3.5 Global Viibryd (Vilazodone) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Viibryd (Vilazodone) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Viibryd (Vilazodone) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Viibryd (Vilazodone) Players in Global Market
  3.8.1 List of Global Tier 1 Viibryd (Vilazodone) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Viibryd (Vilazodone) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Viibryd (Vilazodone) Market Size Markets, 2021 & 2028
  4.1.2 10 mg
  4.1.3 20 mg
  4.1.4 40 mg
4.2 By Type - Global Viibryd (Vilazodone) Revenue & Forecasts
  4.2.1 By Type - Global Viibryd (Vilazodone) Revenue, 2017-2022
  4.2.2 By Type - Global Viibryd (Vilazodone) Revenue, 2023-2028
  4.2.3 By Type - Global Viibryd (Vilazodone) Revenue Market Share, 2017-2028
4.3 By Type - Global Viibryd (Vilazodone) Sales & Forecasts
  4.3.1 By Type - Global Viibryd (Vilazodone) Sales, 2017-2022
  4.3.2 By Type - Global Viibryd (Vilazodone) Sales, 2023-2028
  4.3.3 By Type - Global Viibryd (Vilazodone) Sales Market Share, 2017-2028
4.4 By Type - Global Viibryd (Vilazodone) Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Viibryd (Vilazodone) Market Size, 2021 & 2028
  5.1.2 Major Depression
  5.1.3 Anxiety
  5.1.4 Others
5.2 By Application - Global Viibryd (Vilazodone) Revenue & Forecasts
  5.2.1 By Application - Global Viibryd (Vilazodone) Revenue, 2017-2022
  5.2.2 By Application - Global Viibryd (Vilazodone) Revenue, 2023-2028
  5.2.3 By Application - Global Viibryd (Vilazodone) Revenue Market Share, 2017-2028
5.3 By Application - Global Viibryd (Vilazodone) Sales & Forecasts
  5.3.1 By Application - Global Viibryd (Vilazodone) Sales, 2017-2022
  5.3.2 By Application - Global Viibryd (Vilazodone) Sales, 2023-2028
  5.3.3 By Application - Global Viibryd (Vilazodone) Sales Market Share, 2017-2028
5.4 By Application - Global Viibryd (Vilazodone) Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Viibryd (Vilazodone) Market Size, 2021 & 2028
6.2 By Region - Global Viibryd (Vilazodone) Revenue & Forecasts
  6.2.1 By Region - Global Viibryd (Vilazodone) Revenue, 2017-2022
  6.2.2 By Region - Global Viibryd (Vilazodone) Revenue, 2023-2028
  6.2.3 By Region - Global Viibryd (Vilazodone) Revenue Market Share, 2017-2028
6.3 By Region - Global Viibryd (Vilazodone) Sales & Forecasts
  6.3.1 By Region - Global Viibryd (Vilazodone) Sales, 2017-2022
  6.3.2 By Region - Global Viibryd (Vilazodone) Sales, 2023-2028
  6.3.3 By Region - Global Viibryd (Vilazodone) Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Viibryd (Vilazodone) Revenue, 2017-2028
  6.4.2 By Country - North America Viibryd (Vilazodone) Sales, 2017-2028
  6.4.3 US Viibryd (Vilazodone) Market Size, 2017-2028
  6.4.4 Canada Viibryd (Vilazodone) Market Size, 2017-2028
  6.4.5 Mexico Viibryd (Vilazodone) Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Viibryd (Vilazodone) Revenue, 2017-2028
  6.5.2 By Country - Europe Viibryd (Vilazodone) Sales, 2017-2028
  6.5.3 Germany Viibryd (Vilazodone) Market Size, 2017-2028
  6.5.4 France Viibryd (Vilazodone) Market Size, 2017-2028
  6.5.5 U.K. Viibryd (Vilazodone) Market Size, 2017-2028
  6.5.6 Italy Viibryd (Vilazodone) Market Size, 2017-2028
  6.5.7 Russia Viibryd (Vilazodone) Market Size, 2017-2028
  6.5.8 Nordic Countries Viibryd (Vilazodone) Market Size, 2017-2028
  6.5.9 Benelux Viibryd (Vilazodone) Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Viibryd (Vilazodone) Revenue, 2017-2028
  6.6.2 By Region - Asia Viibryd (Vilazodone) Sales, 2017-2028
  6.6.3 China Viibryd (Vilazodone) Market Size, 2017-2028
  6.6.4 Japan Viibryd (Vilazodone) Market Size, 2017-2028
  6.6.5 South Korea Viibryd (Vilazodone) Market Size, 2017-2028
  6.6.6 Southeast Asia Viibryd (Vilazodone) Market Size, 2017-2028
  6.6.7 India Viibryd (Vilazodone) Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Viibryd (Vilazodone) Revenue, 2017-2028
  6.7.2 By Country - South America Viibryd (Vilazodone) Sales, 2017-2028
  6.7.3 Brazil Viibryd (Vilazodone) Market Size, 2017-2028
  6.7.4 Argentina Viibryd (Vilazodone) Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Viibryd (Vilazodone) Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Viibryd (Vilazodone) Sales, 2017-2028
  6.8.3 Turkey Viibryd (Vilazodone) Market Size, 2017-2028
  6.8.4 Israel Viibryd (Vilazodone) Market Size, 2017-2028
  6.8.5 Saudi Arabia Viibryd (Vilazodone) Market Size, 2017-2028
  6.8.6 UAE Viibryd (Vilazodone) Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Allergan plc (AbbVie Inc.)
  7.1.1 Allergan plc (AbbVie Inc.) Corporate Summary
  7.1.2 Allergan plc (AbbVie Inc.) Business Overview
  7.1.3 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Major Product Offerings
  7.1.4 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales and Revenue in Global (2017-2022)
  7.1.5 Allergan plc (AbbVie Inc.) Key News
7.2 Actavis Generics (Teva)
  7.2.1 Actavis Generics (Teva) Corporate Summary
  7.2.2 Actavis Generics (Teva) Business Overview
  7.2.3 Actavis Generics (Teva) Viibryd (Vilazodone) Major Product Offerings
  7.2.4 Actavis Generics (Teva) Viibryd (Vilazodone) Sales and Revenue in Global (2017-2022)
  7.2.5 Actavis Generics (Teva) Key News
7.3 Clinical Data, Inc.
  7.3.1 Clinical Data, Inc. Corporate Summary
  7.3.2 Clinical Data, Inc. Business Overview
  7.3.3 Clinical Data, Inc. Viibryd (Vilazodone) Major Product Offerings
  7.3.4 Clinical Data, Inc. Viibryd (Vilazodone) Sales and Revenue in Global (2017-2022)
  7.3.5 Clinical Data, Inc. Key News

8 GLOBAL VIIBRYD (VILAZODONE) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Viibryd (Vilazodone) Production Capacity, 2017-2028
8.2 Viibryd (Vilazodone) Production Capacity of Key Manufacturers in Global Market
8.3 Global Viibryd (Vilazodone) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 VIIBRYD (VILAZODONE) SUPPLY CHAIN ANALYSIS

10.1 Viibryd (Vilazodone) Industry Value Chain
10.2 Viibryd (Vilazodone) Upstream Market
10.3 Viibryd (Vilazodone) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Viibryd (Vilazodone) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Viibryd (Vilazodone) in Global Market
Table 2. Top Viibryd (Vilazodone) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Viibryd (Vilazodone) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Viibryd (Vilazodone) Revenue Share by Companies, 2017-2022
Table 5. Global Viibryd (Vilazodone) Sales by Companies, (K Units), 2017-2022
Table 6. Global Viibryd (Vilazodone) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Viibryd (Vilazodone) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Viibryd (Vilazodone) Product Type
Table 9. List of Global Tier 1 Viibryd (Vilazodone) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viibryd (Vilazodone) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Viibryd (Vilazodone) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Viibryd (Vilazodone) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Viibryd (Vilazodone) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Viibryd (Vilazodone) Sales (K Units), 2017-2022
Table 15. By Type - Global Viibryd (Vilazodone) Sales (K Units), 2023-2028
Table 16. By Application – Global Viibryd (Vilazodone) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Viibryd (Vilazodone) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Viibryd (Vilazodone) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Viibryd (Vilazodone) Sales (K Units), 2017-2022
Table 20. By Application - Global Viibryd (Vilazodone) Sales (K Units), 2023-2028
Table 21. By Region – Global Viibryd (Vilazodone) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Viibryd (Vilazodone) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Viibryd (Vilazodone) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Viibryd (Vilazodone) Sales (K Units), 2017-2022
Table 25. By Region - Global Viibryd (Vilazodone) Sales (K Units), 2023-2028
Table 26. By Country - North America Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Viibryd (Vilazodone) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Viibryd (Vilazodone) Sales, (K Units), 2017-2022
Table 29. By Country - North America Viibryd (Vilazodone) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Viibryd (Vilazodone) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Viibryd (Vilazodone) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Viibryd (Vilazodone) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Viibryd (Vilazodone) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Viibryd (Vilazodone) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Viibryd (Vilazodone) Sales, (K Units), 2023-2028
Table 38. By Country - South America Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Viibryd (Vilazodone) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Viibryd (Vilazodone) Sales, (K Units), 2017-2022
Table 41. By Country - South America Viibryd (Vilazodone) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Viibryd (Vilazodone) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Viibryd (Vilazodone) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Viibryd (Vilazodone) Sales, (K Units), 2023-2028
Table 46. Allergan plc (AbbVie Inc.) Corporate Summary
Table 47. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Offerings
Table 48. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Actavis Generics (Teva) Corporate Summary
Table 50. Actavis Generics (Teva) Viibryd (Vilazodone) Product Offerings
Table 51. Actavis Generics (Teva) Viibryd (Vilazodone) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Clinical Data, Inc. Corporate Summary
Table 53. Clinical Data, Inc. Viibryd (Vilazodone) Product Offerings
Table 54. Clinical Data, Inc. Viibryd (Vilazodone) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Viibryd (Vilazodone) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 56. Global Viibryd (Vilazodone) Capacity Market Share of Key Manufacturers, 2020-2022
Table 57. Global Viibryd (Vilazodone) Production by Region, 2017-2022 (K Units)
Table 58. Global Viibryd (Vilazodone) Production by Region, 2023-2028 (K Units)
Table 59. Viibryd (Vilazodone) Market Opportunities & Trends in Global Market
Table 60. Viibryd (Vilazodone) Market Drivers in Global Market
Table 61. Viibryd (Vilazodone) Market Restraints in Global Market
Table 62. Viibryd (Vilazodone) Raw Materials
Table 63. Viibryd (Vilazodone) Raw Materials Suppliers in Global Market
Table 64. Typical Viibryd (Vilazodone) Downstream
Table 65. Viibryd (Vilazodone) Downstream Clients in Global Market
Table 66. Viibryd (Vilazodone) Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Viibryd (Vilazodone) Segment by Type
Figure 2. Viibryd (Vilazodone) Segment by Application
Figure 3. Global Viibryd (Vilazodone) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Viibryd (Vilazodone) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Viibryd (Vilazodone) Revenue, 2017-2028 (US$, Mn)
Figure 7. Viibryd (Vilazodone) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Viibryd (Vilazodone) Revenue in 2021
Figure 9. By Type - Global Viibryd (Vilazodone) Sales Market Share, 2017-2028
Figure 10. By Type - Global Viibryd (Vilazodone) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Viibryd (Vilazodone) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Viibryd (Vilazodone) Sales Market Share, 2017-2028
Figure 13. By Application - Global Viibryd (Vilazodone) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Viibryd (Vilazodone) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Viibryd (Vilazodone) Sales Market Share, 2017-2028
Figure 16. By Region - Global Viibryd (Vilazodone) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Viibryd (Vilazodone) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Viibryd (Vilazodone) Sales Market Share, 2017-2028
Figure 19. US Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Viibryd (Vilazodone) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Viibryd (Vilazodone) Sales Market Share, 2017-2028
Figure 24. Germany Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 25. France Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Viibryd (Vilazodone) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Viibryd (Vilazodone) Sales Market Share, 2017-2028
Figure 33. China Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 37. India Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Viibryd (Vilazodone) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Viibryd (Vilazodone) Sales Market Share, 2017-2028
Figure 40. Brazil Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Viibryd (Vilazodone) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Viibryd (Vilazodone) Sales Market Share, 2017-2028
Figure 44. Turkey Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Viibryd (Vilazodone) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Viibryd (Vilazodone) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Viibryd (Vilazodone) by Region, 2021 VS 2028
Figure 50. Viibryd (Vilazodone) Industry Value Chain
Figure 51. Marketing Channels